Treatment of acrodermatitis continua of Hallopeau with adalimumab

British Journal of Dermatology

Volumn 160, Issue 1, 2009, Pages 203-205

  Ryan, C ^a   Collins, P ^a   Kirby, B ^a   Rogers, S ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Acrodermatitis continua of Hallopeau; Adalimumab

Indexed keywords

ADALIMUMAB; CYCLOSPORIN A; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PSORALEN;

ACRODERMATITIS CONTINUA; ADULT; AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION;

ACRODERMATITIS; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; PSORIASIS; SMOKING; TREATMENT OUTCOME;

EID: 57649242597     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08893.x     Document Type: Letter

References (10)

1. Hallopeau MH. Sur une asphyxie locale des extrémitiés avec polydactilite suppurative chronique et poussées éphé mères de dermatite pustuleuse disséminée et symétrique. Bull Soc Fr Dermatol Syphiligr 1890 1 : 39 45.
2. Yerushalmi J, Grunwald MH, Hallel-Halevy D et al. Chronic pustular eruption of the thumbs. Diagnosis: acrodermatitis continua of Hallopeau (ACH). Arch Dermatol 2000 136 : 925 30.
3. Baker H, Ryan TJ. Generalized pustular psoriasis. Br J Dermatol 1968 80 : 771 93.
4. Nikkels AF, Nikkels-Tassoudji N, Pierard GE. Breaking the relentless course of Hallopeau's acrodermatitis by dapsone. Eur J Dermatol 1999 9 : 126 8.
5. Mang R, Ruzicka T, Stege H. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-α inhibitor infliximab. Br J Dermatol 2004 150 : 379 80.
6. Adişen E, Öztaş M, Gürer MA. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau. Int J Dermatol 2007 46 : 1205 7.
7. Tobin AM, Kirby B. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol 2005 153 : 445 6.
8. Calabrese LH. Molecular differences in anticytokine therapies. Clin Exp Rheumatol 2003 21 : 241 8.
9. Menter A, Tyring SK, Gordon K et al. Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial. J Am Acad Dermatol 2008 58 : 106 15.
10. Gordon KB, Langley RG, Leonardi C et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol 2006 55 : 598 606.